(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-((3R,5S,8S,9S,10S,11S,13S,14S)-11-hydroxy-10,13-dimethyl-17-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)tetrahydro-2H-pyran-2-carboxylic acid 35259-60-0 5alpha-Androstan-3alpha,11beta-diol-17-one 3-glucosiduronate CAS 35259-60-0

Purity 97%+In StockPharmaceutical Standards
CAS No.35259-60-0
Molecular FormulaC25H38O9
Molecular Weight482.56 g/mol
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-((3R,5S,8S,9S,10S,11S,13S,14S)-11-hydroxy-10,13-dimethyl-17-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)tetrahydro-2H-pyran-2-carboxylic acid 35259-60-0 5alpha-Androstan-3alpha,11beta-diol-17-one 3-glucosiduronate CAS 35259-60-0 chemical structure

Description

The occurrence of (2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-((3R,5S,8S,9S,10S,11S,13S,14S)-11-hydroxy-10,13-dimethyl-17-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)tetrahydro-2H-pyran-2-carboxylic acid 35259-60-0 5alpha-Androstan-3alpha,11beta-diol-17-one 3-glucosiduronate is closely related to a flavonoid core, a hydroxyl group, an ether linkage in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.

(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-((3R,5S,8S,9S,10S,11S,13S,14S)-11-hydroxy-10,13-dimethyl-17-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)tetrahydro-2H-pyran-2-carboxylic acid 35259-60-0 5alpha-Androstan-3alpha,11beta-diol-17-one 3-glucosiduronate (CAS 35259-60-0), molecular formula C25H38O9 and molecular weight 482.56 g/mol, is a CATO reference standard with documented purity and traceability.

The molecular framework of (2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-((3R,5S,8S,9S,10S,11S,13S,14S)-11-hydroxy-10,13-dimethyl-17-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)tetrahydro-2H-pyran-2-carboxylic acid 35259-60-0 5alpha-Androstan-3alpha,11beta-diol-17-one 3-glucosiduronate (C25H38O9) is characterized by a flavonoid core, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the polarity and ionization state of its functional groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.

CATO manufactures (2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-((3R,5S,8S,9S,10S,11S,13S,14S)-11-hydroxy-10,13-dimethyl-17-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)tetrahydro-2H-pyran-2-carboxylic acid 35259-60-0 5alpha-Androstan-3alpha,11beta-diol-17-one 3-glucosiduronate under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Molecular FormulaC25H38O9
Molecular Weight482.56 g/mol
AppearanceOff-white to pale yellow crystalline powder
Purity97%+
StorageStore at room temperature, protect from light, keep sealed and dry
Solubility (reference)Soluble in methanol, acetonitrile, DMSO, water (slightly soluble)
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light
Degree of Unsaturation (DBE)7.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1967

Recommended Standards

Why CATO?